TP53 mutations associate with higher in vitro resistance of CLL cells to ofatumumab and rituximab

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

ŠEBEJOVÁ Ludmila ŠRÁMEK Martin JAŠKOVÁ Zuzana BORSKÝ Marek POTĚŠIL David NAVRKALOVÁ Veronika MALČÍKOVÁ Jitka BRYCHTOVÁ Yvona DOUBEK Michael MAYER Jiří POSPÍŠILOVÁ Šárka TRBUŠEK Martin

Year of publication 2013
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.